By transforming human scar cells into blood vessel cells, scientists at Houston Methodist may have discovered a new way to repair damaged tissue.
The method, described in an upcoming issue of Circulation (early online), appeared to improve blood flow, oxygenation, and nutrition to areas in need.
Cardiovascular scientists at Houston Methodist, with colleagues at Stanford University and Cincinnati Children’s Hospital, learned that fibroblasts — cells that causes scarring and are plentiful throughout the human body — can be coaxed into becoming endothelium, an entirely different type of adult cell that forms the lining of blood vessels.
“To our knowledge, this is the first time that trans-differentiation to a therapeutic cell type has been accomplished with a small molecules and proteins,” said Houston Methodist Research Institute Department of Cardiovascular Sciences Chair John Cooke, M.D., Ph.D., the study’s principal investigator. “In this particular case, we’ve found a way to turn fibroblasts into ‘shapeshifters’ nearly on command.”
Cooke said the regenerative medicine approach provides proof-of-concept for a small molecule therapy that could one day be used to improve the healing of cardiovascular damage or other injuries.
Other research groups have managed to generate endothelial cells cells using infectious virus particles specially engineered to deliver gene-manipulating DNA to cells. The DNA encodes proteins called transcription factors to alter gene expression patterns in such a way that cells behave more like endothelial cells.
“There are problems with using viruses to transfer genes into cells,” Cooke said. “This gene therapy approach is more complicated, and using viral vectors means the possibility of causing damage to the patient’s chromosomes. We believe a small-molecule approach to transforming the cells will be far more feasible and safer for clinical therapies.”
The Latest on: Reprogrammed cells
[google_news title=”” keyword=”Reprogrammed cells” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Reprogrammed cells
- A 'gentle touch' molecule confers light tactile sensation in humans—and perhaps in individual cellson March 2, 2024 at 11:40 am
How do these sensory neurons communicate such a wide range of different inputs? In "new research published in Science," the two co-authors of this article and our colleagues have found a force-sensing ...
- What’s in Vogue for SynBio’s Retooling of Nature’s Code?on February 29, 2024 at 4:00 pm
Products developed by bit.bio include ioCells, which are human cells that have been precision reprogrammed from induced pluripotent stem cells. The ioCells shown here (left: vials; right: cell image) ...
- We discovered a ‘gentle touch’ molecule is essential for light tactile sensation in humans – and perhaps in individual cellson February 29, 2024 at 11:06 am
In new research published in Science, the two co-authors of this article and our colleagues have found a force-sensing molecule in nerve cells called ELKIN1, which is specifically involved in ...
- Cure Ventures backs a cell therapy startup targeting Parkinson’son February 29, 2024 at 10:36 am
The startup, Kenai Therapeutics, has raised $82 million and will be chaired by Jeff Jonas, a new Cure partner and former CEO of Sage Therapeutics.
- Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023on February 28, 2024 at 2:05 pm
On track to report initial clinical and translational data from lead CAR T-cell and TIL product candidates in 2024Received Orphan Drug ...
- Using Gravity To Separate T Cells Could Speed Up Cancer Treatmenton February 27, 2024 at 4:00 pm
This means that these cells can be reprogrammed to produce proteins on their surface called chimeric antigen receptors, or CARs. The CARs recognize and bind to specific proteins, or antigens, on the ...
- Review discusses metabolic reprogramming of T cellson February 27, 2024 at 4:00 pm
Epigenetic and transcriptional pathways mediate this response, but the cells also undergo metabolic reprogramming to meet the dynamic biosynthetic demands of proliferation and differentiation.
- Lyell Immunopharma Announces Participation in March Investor Conferenceson February 26, 2024 at 1:05 pm
SOUTH SAN FRANCISCO, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- . (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid ...
- Hooking an anchor on the DNA minor groove to facilitate gene expression during reprogrammingon February 25, 2024 at 3:59 pm
During the reprogramming of somatic cells back into stem cells, gene regulation is controlled by pioneer transcription factors. These bind to the tightly packaged DNA in order to make it accessible.
- Research reveals how cancer hijacks immune cells to promote tumor growthon February 23, 2024 at 7:18 am
A new research study led by A*STAR.Singapore Immunology Network (A*STAR.SIgN) has found that neutrophils—one of the most abundant white blood cells in our body—change ... The study, "Deterministic ...
via Bing News